A registered PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 2
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · NONE
- Evidence population
- Human clinical study registration
- Participants
- 160
- Population
- ALL · 75 Years
- Duration
- 2017-08-01 to 2023-08-01
- Intervention
- Laparoscopic D1 Lymphadenectomy; Laparoscopic D2 Lymphadenectomy
- Comparator
- Laparoscopic D2 Lymphadenectomy
- Outcomes measured
- 3-year disease specific survival rate — 36 months; 3-year overall survival rate — 36 months; 3-year disease free survival rate — 36 months; number of retrieved lymph nodes — 1 day; number of positive lymph nodes — 1 day; intraoperative blood loss — 1 day; the rate of conversion to laparotomy — 1 day; overall postoperative morbidity rate — 30 days; overall postoperative mortality rate — 30 days; Time to first ambulation — 30 days; Time to first flatus — 30 days; Time to first liquid diet — 30 days; Time to first soft diet — 30 days; Duration of postoperative hospital stay — 30 days; The variation of white blood cell count — Preoperative 3 days and postoperative 1, 3, and 5 days; The variation of hemoglobin — Preoperative 3 days and postoperative 1, 3, and 5 days; The variation of C-reactive protein — Preoperative 3 days and postoperative 1, 3, and 5 days; The variation of prealbumin — Preoperative 3 days and postoperative 1, 3, and 5 days; operation time — 1 day
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 80% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cancer and ageing · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.